Skip to content

Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

Spotlight AQ Randomized Controlled Trial of the Spotlight AQ Survey Platform to Evaluate Its' Efficacy and Applicability in a Clinic Setting.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06390371
Enrollment
60
Registered
2024-04-30
Start date
2024-05-18
Completion date
2026-12-01
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Brief summary

The goal of this clinical trial is to compare the Spotlight AQ survey platform to the standard of care (SOC) pre-clinic assessment in adolescents & young adults (16-25 years old) with Type 1 Diabetes (T1D). The main questions it aims to answer are: * Does using the Spotlight AQ survey in clinic decrease the A1c in the people who use it? * Do patients and healthcare providers like using the spotlight AQ survey? Participants will use the Spotlight AQ survey before coming in to two standard of care T1D clinic visits Participants will fill out surveys describing how they feel about using the Spotlight AQ survey. Some participants may be asked to do an interview to talk about how they feel about the Spotlight AQ survey.

Interventions

OTHERSpotlight AQ Survey platform

A psychosocial assessment pinpointing the needs of patients divided into four domains: Therapy, Psychological, Social, Knowledge which is delivered to health care providers to guide their in clinic visits

Sponsors

Children's Mercy Hospital Kansas City
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* 16-25 years old * Patients diagnosed with T1D for at least 6 months * On any diabetes treatment * Using a Continuous Glucose Monitor (CGM) * Willing/ able to use Spotlight AQ tool * Able to give verbal assent * Patients \& parents/caregiver speak English/ Spanish fluently * Patients in the Children's Mercy Kansas City Hospital or Boston Children's Hospital network

Exclusion criteria

* \<16 years old or \>25 years old * Mental illness that could seriously reduce their ability to participate in the study * Lack of capacity * In another T1D intervention study

Design outcomes

Primary

MeasureTime frameDescription
HbA1c3 months (approximately)HbA1c levels of pediatric participants as a %

Secondary

MeasureTime frameDescription
Participant satisfaction3 months (approximately)Participant satisfaction with the survey as measured by the End of Study questionnaires. Participants indicate being unsatisfied- satisfied or not helped- helped, etc. within the questionnaires
HCP satisfaction with the Spotlight survey3 months (approximately)Healthcare Provider (HCP) satisfaction with the Spotlight survey as measured by their End of Study questionnaires. HCPs indicate being unsatisfied- satisfied or not helped- helped, etc. within the questionnaires
T1D outcomes3 months (approximately)T1D outcomes including Time in Range
The effectiveness of the intervention3 months (approximately)The effectiveness evaluated in qualitative studies
The approval of participants3 months (approximately)The approval of participants evaluated in qualitative studies

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCintya Schweisberger, DO

Children's Mercy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026